Amneal Pharmaceuticals, Inc Class A Common Stock
Price & Volume
Stats
See moreOpen | $17.27 |
Previous Close | $17.32 |
Day Range | $17.25-$17.82 |
52W Range | $7.66-$17.77 |
Market Cap | $5.5B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $3B |
Revenue Growth (YoY) | 3.9% |
Gross Profit (12 Mos) | $1.1B |
Diluted EPS | $0.37 |
News
See moreYahoo Finance • 21 days ago
How The Amneal Pharmaceuticals (AMRX) Story Is Shifting With Biosimilars And 2026 Expectations
Yahoo Finance • 21 days ago
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease
Yahoo Finance • 30 days ago
Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
Yahoo Finance • last month
2 Reasons AMRX is Risky and 1 Stock to Buy Instead
About
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 8,700 |